½ÃÀ庸°í¼­
»óǰÄÚµå
1705645

¼¼°èÀÇ Á¤¸ÆÁÖ»ç¾× ½ÃÀå : ¿ë¾×º°, °¡¹æ À¯Çüº°, ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº° ½ÃÀå ±Ô¸ð, Á¡À¯À², Àü¸Á, ±âȸ ºÐ¼®(2025-2032³â)

Intravenous Solutions Market, by Solution, by Bag Type, by Application, by End User, and by Region Size, Share, Outlook, and Opportunity Analysis, 2025 - 2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Coherent Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ Á¤¸ÆÁÖ»ç¾× ½ÃÀåÀº 2025³â 110¾ï 5,000¸¸ ´Þ·¯·Î ÃßÁ¤µÇ°í, 2032³â±îÁö 169¾ï 5,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ°í, 2025³âºÎÅÍ 2032³â±îÁö ¿¬Æò±Õ ¼ºÀå·ü(CAGR) 6.3%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

º¸°í ¹üÀ§ º¸°í¼­ ¼¼ºÎÁ¤º¸
±âÁØ¿¬µµ 2024³â 2025³â ½ÃÀå ±Ô¸ð 110¾ï 5,000¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2020-2024³â ¿¹Ãø ±â°£ 2025-2032³â
¿¹Ãø ±â°£: 2025-2032³â CAGR: 6.30% 2032³â °¡Ä¡ ¿¹Ãø 169¾ï 5,000¸¸ ´Þ·¯
±×¸². Á¤¸ÆÁÖ»ç¾× ½ÃÀå Á¡À¯À²(%), 2025³â Áö¿ªº°
Intravenous Solutions Market-IMG1

Á¤¸Æ³» ¼Ö·ç¼ÇÀº Á¤¸Æ ¼øÈ¯¿¡ Á÷Á¢ Åõ¿©µÇ´Â ü¾×ÀÔ´Ï´Ù. ÀÌ ÁÖÀÔÀº ¸ê±Õ ºñ ÆÄÀÌ·ÎÁ¨ ¼Ö·ç¼Ç, Á¤¸Æ ³» Åõ¿©¸¦ À§ÇÑ ´ÜÀÏ ¿ë·® ¿ë±â¿¡ ³Ö¾î ¼öºÐ ¹× Ä®·Î¸® º¸±Þ¿¡ »ç¿ëµË´Ï´Ù. ¿°È­³ªÆ®·ý, Á¥»ê ¸µ°Å, ¼öÁß Æ÷µµ´ç µî ½ÃÀå¿¡¼­ ÀÌ¿ë °¡´ÉÇÑ Á¤¸ÆÁÖ»ç¾×¿¡´Â ¿©·¯ À¯ÇüÀÌ ÀÖ½À´Ï´Ù. Á¡Àû ¿ä¹ýÀº ¿µ¾ç ºÎÁ·À̳ª Å»¼ö·Î °íÅë¹Þ´Â ȯÀÚ¿¡°Ô ÀÌ»óÀûÀÔ´Ï´Ù. Å»¼ö´Â ´ÙÀ½°ú °°Àº ´Ù¾çÇÑ ¿µÇâÀ» À¯¹ßÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÅüÀÇ Áß¿äÇÑ ¹Ì³×¶ö(ÀüÇØÁú) ±ÕÇü
  • ÀÎÁö(Á¤½Å) ´É·Â
  • ¿¡³ÊÁö ·¹º§
  • À§Àå ±â´É(À½½ÄÀ» ¼ÒÈ­ÇÏ°í ´ë¼Òº¯À» ¸¸µå´Â ´É·Â)
  • µÎÅëÀÇ ºóµµ¿Í °­µµ
  • ½Åü ´É·Â
  • ÇǺΠ°Ç°­ »óÅÂ

½ÃÀå ¿ªÇÐ

¼³»çÁõÀÇ À¯º´·ü Áõ°¡´Â ¿¹Ãø ±â°£ µ¿¾È ¼¼°è Á¤¸ÆÁÖ»ç¾× ½ÃÀåÀÇ ¼ºÀåÀ» ¹Ð¾î¿Ã¸± °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¿¹¸¦ µé¾î, 2022³â 7¿ù, ¼¼°è ¾î¸°À̵鿡°Ô ÀεµÀû ¹× °³¹ßÀû ¿øÁ¶¸¦ Á¦°øÇÏ´Â À¯¿£ÀÇ ±â°üÀÎ UNICEF(UN ±¹Á¦ ¾Æµ¿ ±ä±Þ ±â±Ý)´Â ¼³»ç¿¡ ÀÇÇÑ 2020³â ¼¼°èÀÇ 5¼¼ ¹Ì¸¸ ¾Æµ¿ÀÇ Àüü »ç¸ÁÀÇ 9%¸¦ Â÷ÁöÇÏ´Â ÇÑÆí, ¼³»ç¿¡ ÀÇÇØ ¸ÅÀÏ 1,300¸í ÀÌ»óÀÇ À¯¾Æ°¡ »ç¸ÁÇØ, ¼¼°è Àüü¿¡¼­ ¿¬°£ ¾à 48¸¸ 4,000¸íÀÇ ¾ÆÀ̰¡ »ç¸ÁÇϰí ÀÖ´Ù°í ÇÏ´Â º¸°í¼­¸¦ ¹ßÇ¥Çß½À´Ï´Ù.

°Ô´Ù°¡ 2018³â 9¿ù Lancet Infectious Diseases¿¡ °ÔÀçµÈ ³í¹®¿¡ µû¸£¸é ¼³»ç´Â 2016³â Àå¾ÖÁ¶Á¤ »ýÁ¸³â(DALYs)ÀÇ Á¦3À§ÀÇ ¿øÀÎÀ̸ç, Àü ¼¼°èÀûÀ¸·Î 7,440¸¸ DALYs¸¦ Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ÀÌ Ãâó¿¡ µû¸£¸é ¼³»ç´Â »ç¸Á ¿øÀÎ Áß 8À§¿´À¸¸ç, 2016³â »ç¸ÁÀÚ ¼ö´Â Àü ¼¼°èÀûÀ¸·Î 165¸¸ 5,944¸íÀ̾ú½À´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

  • º» º¸°í¼­¿¡¼­´Â ¼¼°è Á¤¸ÆÁÖ»ç¾× ½ÃÀå¿¡ ´ëÇØ 2024³âÀ» ±âÁØ¿¬µµ·Î ÇÑ ¿¹Ãø±â°£(2025-2032³â) ½ÃÀå ±Ô¸ð¸¦ »ó¼¼ÇÏ°Ô ºÐ¼®Çß½À´Ï´Ù.
  • ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀûÀÎ ¼öÀÍ ±âȸ¸¦ ÇØ¸íÇØ, ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.
  • ¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç°ÀÇ »ó½Ã³ª ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÌ Ã¤¿ëÇÏ´Â °æÀï Àü·« µî¿¡ °üÇÑ Áß¿äÇÑ °íÂûµµ Á¦°øÇÕ´Ï´Ù.
  • ±â¾÷ °³¿ä, À繫 ½ÇÀû, Á¦Ç° Æ÷Æ®Æú¸®¿À, Áö¸®Àû Á¸Àç, À¯Åë Àü·«, ÁÖ¿ä ¹ßÀü, Àü·« µîÀÇ ÆÄ¶ó¹ÌÅ͸¦ ¹ÙÅÁÀ¸·Î ¼¼°èÀÇ Á¡Àû ¼Ö·ç¼Ç ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏÀ» Á¦°øÇÕ´Ï´Ù.
  • º» º¸°í¼­ÀÇ ÀλçÀÌÆ®¿¡ ÀÇÇØ ±â¾÷ÀÇ ¸¶ÄÉÆÃ ´ã´çÀÚ³ª °æ¿µÁøÀº Àå·¡ÀÇ Á¦Ç° ¹ß¸Å, Á¤ºÎÀÇ ´ëó, ±â¼ú Çâ»ó, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü¼ú¿¡ °üÇØ¼­, Á¤º¸¿¡ ±Ù°ÅÇÑ ÀÇ»ç °áÁ¤À» ½Ç½ÃÇÒ ¼ö ÀÖ½À´Ï´Ù.
  • ÀÌ Á¶»ç º¸°í¼­´Â ÅõÀÚÀÚ, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ÀÌÇØ°ü°èÀÚ, ¸®¼­Ä¡»ç, ÄÁ¼³ÆÃ ȸ»ç, ½Å±Ô Âü°¡±â¾÷, À繫 ºÐ¼®°¡ µî ÀÌ ¾÷°èÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î Çϰí ÀÖ½À´Ï´Ù.
  • ÀÌÇØ°ü°èÀÚ´Â ¼¼°èÀÇ Á¤¸ÆÁÖ»ç¾× ½ÃÀåÀÇ ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ, ÀÇ»ç °áÁ¤À» ¿ëÀÌÇÏ°Ô ÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»çÀÇ ¸ñÀû°ú ÀüÁ¦Á¶°Ç

  • Á¶»ç ¸ñÀû
  • ÀüÁ¦Á¶°Ç
  • ¾à¾î

Á¦2Àå ½ÃÀå Àü¸Á

  • º¸°í¼­ ¼³¸í
    • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
  • ÁÖ¿ä ¿ä¾à
  • Coherent Opportunity Map(COM)

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¾ïÁ¦¿äÀÎ
    • ½ÃÀå ±âȸ
  • ¿µÇ⠺м®
  • ½ÃÀå µ¿Çâ
  • ÁÖ¿ä ¹ßÀü
  • ¿ªÇÐ
  • Porter's Five Forces ºÐ¼®

Á¦4Àå ¼¼°èÀÇ Á¤¸ÆÁÖ»ç¾× ½ÃÀå - Äڷγª ¹ÙÀÌ·¯½º(COVID-19) ÆÒµ¥¹ÍÀÇ ¿µÇâ

  • ÀüüÀûÀÎ ¿µÇâ
  • COVID-19¿¡ ÀÇÇÑ ½ÃÀå¿¡ ´ëÇÑ ¿µÇâ

Á¦5Àå ¼¼°èÀÇ Á¤¸ÆÁÖ»ç¾× ½ÃÀå : ¿ë¾×º°, 2020-2032³â

  • »ý¸® ½Ä¿°¼ö
  • »ý¸® ½Ä¿°¼ö(0.9% NaCl)
  • °íÀå ½Ä¿°¼ö
  • µ¦½ºÆ®¶õ
  • Á¥»ê ¸µ°Å¾×
  • ¾Æ¹Ì³ë»ê
  • ºñŸ¹Î ¹× ¹Ì³×¶ö
  • ÇìÆÄ¸° ¹× ¹Ì·® ¿ø¼Ò
  • È¥ÇÕ ¼Ö·ç¼Ç

Á¦6Àå ¼¼°èÀÇ Á¤¸ÆÁÖ»ç¾× ½ÃÀå : °¡¹æ À¯Çüº°, 2020-2032³â

  • ´ë¿ë·® °¡¹æ(250ml ÀÌ»ó)
  • ¼Ò¿ë·® °¡¹æ(250ml ¹Ì¸¸)

Á¦7Àå ¼¼°èÀÇ Á¤¸ÆÁÖ»ç¾× ½ÃÀå : ¿ëµµº°, 2020-2032³â

  • ±âº» IV ¿ë¾×
  • ¿µ¾ç IV ¿ë¾×
  • Ç÷¾× IV ¿ë¾×
  • ¾àÁ¦ IV ¿ë¾×
  • °ü°³ IV ¿ë¾×

Á¦8Àå ¼¼°èÀÇ Á¤¸ÆÁÖ»ç¾× ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°, 2020-2032³â

  • º´¿ø
  • Ŭ¸®´Ð
  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • °¡Á¤Ä¡·á ȯ°æ

Á¦9Àå ¼¼°èÀÇ Á¤¸ÆÁÖ»ç¾× ½ÃÀå : Áö¿ªº°, 2020-2032³â

  • ºÏ¹Ì
  • ¶óƾ¾Æ¸Þ¸®Ä«
  • À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áßµ¿
  • ¾ÆÇÁ¸®Ä«

Á¦10Àå °æÀï ±¸µµ

  • È÷Æ®¸Ê ºÐ¼®
  • ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • Baxter International Inc.
    • ICU Medical, Inc.
    • B. Braun Melsungen Ag
    • Grifols, SA
    • Fresenius Kabi USA, LLC
    • Vifor Pharma Management Ltd.
    • JW Life Science
    • Amanta Healthcare
    • Axa Parenterals Ltd
    • Salius Pharma Private Limited.
    • Pfizer, Inc.
    • Otsuka Pharmaceutical Co., Ltd
    • Ajinomoto Co., Inc.
    • Braun Melsungen AG
    • Soxa Formulations & Research Pvt. Ltd
    • Sichuan Kelun Pharmaceutical Co Ltd

Á¦11Àå ºÐ¼®°¡ Ãßõ

  • ¿î¸íÀÇ ¿ø
  • ¾Ö³Î¸®½ºÆ®ÀÇ °ßÇØ
  • Àϰü¼º ÀÖ´Â ±âȸ ¸Ê

Á¦12Àå ¼½¼Ç

  • Âü°í¹®Çå
  • Á¶»ç ¹æ¹ý
JHS 25.05.23

Global Intravenous Solutions Market is estimated to be valued at USD 11.05 Bn in 2025 and is expected to reach USD 16.95 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.3% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 11.05 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 6.30% 2032 Value Projection: USD 16.95 Bn
Figure. Intravenous Solutions Market Share (%), By Region 2025
Intravenous Solutions Market - IMG1

Intravenous solutions are fluids, which are administrated to a patient directly into the venous circulation. These fluids are sterile, non-pyrogenic solutions used for fluid replenishment and caloric supply in single dose container for intravenous administration. There are various types of intravenous solutions available in the market such as sodium chloride, lactated ringers, dextrose in water, and others. Intravenous therapy is ideal for patients suffering from nutritional deficiency and dehydration. Dehydration can contribute to various affects such as

  • Balance of important minerals (electrolytes) in the body.
  • Cognitive (mental) performance.
  • Energy level.
  • Gastrointestinal function (your ability to digest food and create pee and poop).
  • Headache frequency and intensity.
  • Physical performance.
  • Skin health.

Market Dynamics

Increasing prevalence of diarrhoea is expected to boost the global intravenous solution market growth over the forecast period. For instance, in July 2022, UNICEF (United Nations International Children's Emergency Fund), an agency of the United Nations responsible for providing humanitarian and developmental aid to children worldwide, published a report which accounted for 9 per cent of all deaths among children under age 5 worldwide in 2020 due to Diarrhoea, whereas over 1,300 young children dying each day, or about 484,000 children a year globally due to diarrhoea.

Moreover, according to an article published in the Lancet Infectious Diseases, September 2018, diarrhoea was the third leading cause of disability-adjusted life year (DALYs) in 2016, which accounted for 74.4 million DALYs, globally. According to the same source, diarrhoea was the eighth leading cause of death, which accounted for 1,655,944 deaths in 2016 globally.

Key features of the study:

  • This report provides an in-depth analysis of the global intravenous solutions market, market size (US$ Bn), and compound annual growth rate (CAGR (%)) for the forecast period: 2025 - 2032, considering 2024 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
  • It profiles key players in the global intravenous solutions market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include, Baxter International Inc. ICU Medical, Inc, B. Braun Melsungen Ag, Grifols, S.A., Fresenius Kabi USA, LLC, Vifor Pharma Management Ltd, JW Life Science, Amanta Healthcare, Axa Parenterals Ltd, and Salius Pharma Private Limited, Pfizer, Inc, Otsuka Pharmaceutical Co., Ltd, Ajinomoto Co., Inc., B. Braun Melsungen AG, Soxa Formulations & Research Pvt.Ltd, Sichuan Kelun Pharmaceutical Co Ltd.
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The global intravenous solutions market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, suppliers, research and consulting firms, new entrants, and financial analysts
  • Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global intravenous solutions market.

Detailed Segmentation:

  • Global Intravenous Solutions Market, By Solution type:
    • Saline
    • Normal Saline (0.9% NaCl)
    • Hypertonic Saline
    • Dextran
    • Lactated Ringer's
    • Amino Acid
    • Vitamins & Minerals
    • Heparin and Trace Elements
    • Mixed Solutions
  • Global Intravenous Solutions Market, By Bag type:
    • Large Volume Bags (greater than 250ml)
    • Small Volume Bags (less than 250ml)
  • Global Intravenous Solutions Market, By Application:
    • Basic IV Solution
    • Nutritional IV Solution
    • Blood IV Solution
    • Drug IV Solution
    • Irrigation IV Solution
  • Global Intravenous Solutions Market, By End User:
    • Hospitals
    • Clinics
    • Ambulatory Surgery Centers
    • Home Care Settings
  • Global Intravenous Solutions Market, By Region:
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Company Profiles
    • Baxter International Inc.
    • ICU Medical, Inc.
    • Braun Melsungen Ag
    • Grifols, S.A.
    • Fresenius Kabi USA, LLC
    • Vifor Pharma Management Ltd.
    • JW Life Science
    • Amanta Healthcare
    • Axa Parenterals Ltd.
    • Salius Pharma Private Limited.
    • Pfizer, Inc.
    • Otsuka Pharmaceutical Co., Ltd
    • Ajinomoto Co., Inc.
    • Braun Melsungen AG
    • Soxa Formulations & Research Pvt.Ltd
    • Sichuan Kelun Pharmaceutical Co Ltd

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Solution
    • Market Snapshot, By Bag Type
    • Market Snapshot, By Application
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Epidemiology
  • Porter's Five Forces Analysis

4. Global Intravenous Solutions Market- Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • COVID-19 Impact on the market

5. Global Intravenous Solutions Market, By Solution, 2020 - 2032, (US$ Billion)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Saline
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Normal Saline (0.9% NaCl)
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Hypertonic Saline
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Dextran
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Lactated Ringer's
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Amino Acid
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Vitamins & Minerals
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Heparin and trace elements
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Mixed Solutions
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

6. Global Intravenous Solutions Market, By Bag Type, 2020 - 2032, (US$ Billion)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021- 2032
    • Segment Trends
  • Large Volume Bags (greater than 250ml)
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Small Volume Bags (less than 250ml)
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

7. Global Intravenous Solutions Market, By Application, 2020 - 2032, (US$ Billion)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021- 2032
    • Segment Trends
  • Basic IV Solution
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Nutritional IV Solution
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Blood IV Solution
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Drug IV Solution
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Irrigation IV Solution
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

8. Global Intravenous Solutions Market, By End User, 2020 - 2032, (US$ Billion)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospital
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Clinics
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Ambulatory Surgery Centers
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Home care Settings
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

9. Global Intravenous Solutions Market, By Region, 2020 - 2032, (US$ Billion)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Regions, 2021-2032
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Solution, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Bag Type, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Solution, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Bag Type, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Solution, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Bag Type, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Solution, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Bag Type, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Solution, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Bag Type, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Solution, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Bag Type, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (US$ Billion)
      • North Africa
      • Central Africa
      • South Africa

10. Competitive Landscape

  • Heat Map Analysis
  • Company Profile
    • Baxter International Inc.
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • ICU Medical, Inc.
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • B. Braun Melsungen Ag
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • Grifols, S.A
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • Fresenius Kabi USA, LLC
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • Vifor Pharma Management Ltd.
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • JW Life Science
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • Amanta Healthcare
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • Axa Parenterals Ltd
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • Salius Pharma Private Limited.
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • Pfizer, Inc.
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • Otsuka Pharmaceutical Co., Ltd
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • Ajinomoto Co., Inc.
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • Braun Melsungen AG
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • Soxa Formulations & Research Pvt. Ltd
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • Sichuan Kelun Pharmaceutical Co Ltd
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies

11. Analyst Recommendation

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

12. Section

  • References
  • Research Methodology
  • About Us and Sales Contact
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦